ask="N/A"
ask_size="N/A"
average_daily_volume="371115"
bid="1.00"
bid_size="100"
book_value="14.89"
change="+1.71"
change_from_200_day_moving_average="-2.30"
change_from_50_day_moving_average="0.46"
change_from_52_week_high="-13.24"
change_From_52_week_low="17.39"
change_in_percent="+3.71%"
close="47.74"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="23962000"
high="47.79"
high_52_weeks="60.98"
last_trade_date="2/15/2017"
last_trade_price="47.74"
last_trade_size="12942"
last_trade_time="4:00pm"
low="46.07"
low_52_weeks="30.35"
market_capitalization="1.30B"
moving_average_200_day="50.04"
moving_average_50_day="47.28"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="46.07"
pe_ratio="5.33"
peg_ratio="0.34"
percent_change_from_200_day_moving_average="-4.60%"
percent_change_from_50_day_moving_average="+0.98%"
percent_change_from_52_week_high="-21.71%"
percent_change_from_52_week_low="+57.30%"
previous_close="46.03"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.09"
price_per_sales="3.24"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.80"
stock_exchange="NMS"
symbol="FPRX"
volume="185554"
weeks_range_52="30.35 - 60.98"
